Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold [Phase 3]

View source ↗

Summary

A phase 3 randomized controlled trial evaluating an aspirin-lidocaine lozenge for symptomatic treatment of sore throat in common cold; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin-Lidocaine lozenge (aspirin_lidocaine_lozenge)

Snippet

Sponsor: Bayer | Conditions: Common Cold, Pharyngitis | Phase 3 | Status: COMPLETED